These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7544883)

  • 1. Laser ablation of prostatic hypertrophy.
    Strauss BS
    N J Med; 1995 Jul; 92(7):455-8. PubMed ID: 7544883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
    Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
    BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis of laser prostatectomy].
    Xue J; Zhuang H; Wang J; Zhao T; Liu J
    Zhonghua Wai Ke Za Zhi; 1998 Jun; 36(6):370-2. PubMed ID: 11825415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transurethral noncontact laser ablation of the large prostate].
    Xue J; Zhuang H; Wang J
    Zhonghua Wai Ke Za Zhi; 1996 Aug; 34(8):508-10. PubMed ID: 9594203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy.
    Elmansy HM; Elzayat EA; Sampalis JS; Elhilali MM
    Urology; 2009 Nov; 74(5):1105-10. PubMed ID: 19773035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transurethral laser therapy and urinary tract infections.
    Miller J; Ludwig M; Schroeder-Printzen I; Schiefer HG; Weidner W
    Ann Urol (Paris); 1996; 30(3):131-8. PubMed ID: 8766150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of the surgical procedure for management of benign prostatic hyperplasia.
    Mebust WK
    Prog Clin Biol Res; 1994; 386():369-84. PubMed ID: 7528405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
    Bruskewitz R; Issa MM; Roehrborn CG; Naslund MJ; Perez-Marrero R; Shumaker BP; Oesterling JE
    J Urol; 1998 May; 159(5):1588-93; discussion 1593-4. PubMed ID: 9554360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study.
    Zlotta AR; Raviv G; Peny MO; Noel JC; Haot J; Schulman CC
    J Urol; 1997 Mar; 157(3):894-9. PubMed ID: 9072594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Holmium laser versus transurethral resection of the prostate: a randomized prospective trial with 1-year followup.
    Gilling PJ; Mackey M; Cresswell M; Kennett K; Kabalin JN; Fraundorfer MR
    J Urol; 1999 Nov; 162(5):1640-4. PubMed ID: 10524887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Holmium laser enucleation of the prostate and holmium laser ablation of the prostate: indications and outcome.
    Suardi N; Gallina A; Salonia A; Briganti A; Dehò F; Zanni G; Abdollah F; Naspro R; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    Curr Opin Urol; 2009 Jan; 19(1):38-43. PubMed ID: 19057214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference range of prostate-specific antigen after transurethral resection of the prostate.
    Aus G; Bergdahl S; Frösing R; Lodding P; Pileblad E; Hugosson J
    Urology; 1996 Apr; 47(4):529-31. PubMed ID: 8638362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Instrumental treatments for benign prostatic obstruction.
    Seki N; Naito S
    Curr Opin Urol; 2007 Jan; 17(1):17-21. PubMed ID: 17143106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study.
    Gujral S; Abrams P; Donovan JL; Neal DE; Brookes ST; Chacko KN; Wright MJ; Timoney AG; Peters TJ
    J Urol; 2000 Jul; 164(1):59-64. PubMed ID: 10840425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of lower urinary tract symptoms secondary to benign prostatic hyperplasia with open prostatectomy: results of a contemporary series.
    Helfand B; Mouli S; Dedhia R; McVary KT
    J Urol; 2006 Dec; 176(6 Pt 1):2557-61; discussion 2561. PubMed ID: 17085158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Holmium laser enucleation for prostate adenoma greater than 100 gm.: comparison to open prostatectomy.
    Moody JA; Lingeman JE
    J Urol; 2001 Feb; 165(2):459-62. PubMed ID: 11176396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Visual laser ablation of the prostate--a prospective study].
    Jung P; Mersdorf A; Mattelaer P; Jakse G
    Urologe A; 1995 Nov; 34(6):461-5. PubMed ID: 8848857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives.
    Schatzl G; Madersbacher S; Lang T; Marberger M
    J Urol; 1997 Jul; 158(1):105-10; discussion 110-1. PubMed ID: 9186334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cryosurgical ablation for aged patients with severe benign prostate hyperplasia: a report of 21 cases].
    Wang AX; Wang D; Tong W
    Zhonghua Nan Ke Xue; 2007 May; 13(5):421-3. PubMed ID: 17569258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.